The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that have low P/B and P/E ratios, along with low debt and solid long-term earnings growth.
Each of the major indices were up by more than 1% at their highest points of Monday’s session. However, the end result was very different as that rally was spoiled by a late-session selloff that not even technology could save.
In fact, the tech sector led the move lower, se
A sports gambling legalization wave is under way. In May 2018, The Supreme Court overturned a federal law passed in 1992 that banned sports gambling in most states. Since then, 22 states (plus Washington, D.C.) have legalized the activity.
A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".
U.S. consumer prices increased by the most in nearly eight years in June as businesses reopened, but the underlying trend suggested inflation would remain muted and allow the Federal Reserve to keep injecting money into the ailing economy.
Technology stocks were mixed premarket Tuesday as the Technology Select Sector SPDR ETF (XLK) was down 0.79% and the Semiconductor Sector Index Fund (SOXX) was 0.15% higher in recent trading.
Intellia Therapeutics (NASDAQ: NTLA) is a biotech company that focuses on gene editing, a relatively new technology that could allow scientists to devise therapies for otherwise impossible-to-treat conditions. As with any new technology, those who invest in it early enough could
Sterling fell towards the $1.25 mark on Tuesday and reached a two-week low against the euro after new data showed Britain's economy was recovering more slowly than forecast.
Some might think of big pharmaceutical companies as cutthroat corporations only interested in their own profits and self-preservation. But what if told you that several big pharma companies are together investing close to $1 billion to help smaller biotechs?
U.S. automaker Tesla Inc has met with officials from a district in the city of Chongqing in southwestern China to discuss "accelerating projects", the Liangjiang New Area said on Tuesday.
Turkish house sales leapt nearly 210% year-on-year to 190,012 properties in June, official data showed on Tuesday, rebounding with the help of cheap loans as the economy began to revive after Turkey eased coronavirus containment measures.
Most of the major Middle East stock markets eased on Tuesday, after International Monetary Fund revised its growth projections downwards for the region due to the double blows of lower oil prices and the coronavirus crisis. [nL5N2EJ0EB]
Australia's Woodside Petroleum Ltd on Tuesday forecast a first-half impairment loss of $4.37 billion after tax, joining global energy majors that have slashed the value of their assets after a coronavirus-induced slump in oil prices.
Germany's FMS Wertmanagement [FMSWA.UL] on Tuesday invited bids for Dublin-based credit institution Depfa bank, as the German government seeks to draw a line under the country's largest bailout of the financial crisis a decade ago.
Swiss drugmaker Roche on Tuesday struck a deal worth up to $1.7 billion with Blueprint Medicines to develop and commercialise a new treatment for people with so-called RET-altered cancers whose mutations can drive tumour growth.
Checked
8 minutes 49 seconds ago
This feed is responsible for generating the rss feed related to the topic latest article